ArticleOncoimmunology2020

Tivozanib mediated inhibition of c-Kit/SCF signaling on Tregs and MDSCs and reversal of tumor induced immune suppression correlates with survival of HCC patients.

Suresh Gopi Kalathil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.